BRPI0808422A2 - Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas - Google Patents
Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicasInfo
- Publication number
- BRPI0808422A2 BRPI0808422A2 BRPI0808422-0A BRPI0808422A BRPI0808422A2 BR PI0808422 A2 BRPI0808422 A2 BR PI0808422A2 BR PI0808422 A BRPI0808422 A BR PI0808422A BR PI0808422 A2 BRPI0808422 A2 BR PI0808422A2
- Authority
- BR
- Brazil
- Prior art keywords
- inflammatory
- treatment
- organic compounds
- compounds suitable
- allergic conditions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07103600 | 2007-03-06 | ||
PCT/EP2008/052614 WO2008107436A1 (en) | 2007-03-06 | 2008-03-04 | Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0808422A2 true BRPI0808422A2 (pt) | 2015-06-23 |
Family
ID=38442510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0808422-0A BRPI0808422A2 (pt) | 2007-03-06 | 2008-03-04 | Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas |
Country Status (11)
Country | Link |
---|---|
US (2) | US8633211B2 (pt) |
EP (1) | EP2132186A1 (pt) |
JP (1) | JP5390407B2 (pt) |
KR (1) | KR20090115953A (pt) |
CN (1) | CN101622234B (pt) |
AU (1) | AU2008223831B2 (pt) |
BR (1) | BRPI0808422A2 (pt) |
CA (1) | CA2678492A1 (pt) |
EA (1) | EA200901167A1 (pt) |
MX (1) | MX2009009492A (pt) |
WO (1) | WO2008107436A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008154470A1 (en) * | 2007-06-08 | 2008-12-18 | University Of Connecticut | Nhibitor of the receptor activity of the s1p2 receptor for inhibiting pathological angiogenesis in the eye |
WO2010030976A2 (en) * | 2008-09-12 | 2010-03-18 | University Of Connecticut | Methods and compositions for inhibiting atherosclerosis and vascular inflammation |
ES2562183T3 (es) * | 2010-03-26 | 2016-03-02 | Merck Patent Gmbh | Benzonaftiridinaminas como inhibidores de la autotaxina |
KR20130069640A (ko) * | 2010-04-23 | 2013-06-26 | 키네타, 인크. | 항-바이러스 화합물 |
CN102565253A (zh) * | 2010-12-16 | 2012-07-11 | 中国人民解放军第二军医大学 | 一种小分子代谢物图谱及其制作方法和用途 |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
EP2471776A1 (de) | 2010-12-28 | 2012-07-04 | Bayer CropScience AG | Pyridin-2-ylpropandinitrile und deren Verwendung als Herbizide |
GB201104600D0 (en) | 2011-03-18 | 2011-05-04 | Pronoxis Ab | New compounds and medical uses |
WO2012164103A2 (en) | 2011-06-03 | 2012-12-06 | Universität Zürich | Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair |
US20140227321A1 (en) * | 2011-09-30 | 2014-08-14 | Kineta, Inc. | Anti-viral compounds |
LT3176170T (lt) | 2012-06-13 | 2019-04-25 | Incyte Holdings Corporation | Pakeisti tricikliniai junginiai, kaip fgfr inhibitoriai |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
EP2962698B1 (en) | 2013-03-01 | 2021-05-12 | Life Science Institute, Inc. | Pharmaceutical composition including migratory factor for guiding pluripotent stem cells to injury |
WO2014158302A1 (en) * | 2013-03-25 | 2014-10-02 | Swenson Rolf Eric | Novel sphingosine 1-phosphate receptor antagonists |
DK2986610T5 (en) | 2013-04-19 | 2018-12-10 | Incyte Holdings Corp | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
CN104910069B (zh) * | 2014-12-15 | 2018-03-23 | 北京科技大学 | 氨茴酸类衍生物、其制备方法及其在医药上的用途 |
CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
WO2018014862A1 (zh) * | 2016-07-22 | 2018-01-25 | 南京明德新药研发股份有限公司 | S1p1激动剂及其应用 |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
GB201710851D0 (en) * | 2017-07-06 | 2017-08-23 | Galápagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis |
WO2019213506A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
PE20210920A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Formas solidas de un inhibidor de fgfr y procesos para prepararlas |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
KR20220100879A (ko) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Fgfr 저해제로서의 이환식 헤테로사이클 |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
PE20221504A1 (es) | 2019-12-04 | 2022-09-30 | Incyte Corp | Derivados de un inhibidor de fgfr |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2436781A1 (fr) * | 1978-09-19 | 1980-04-18 | Berri Balzac | Derives d'amino-3 (1h,3h) quinazolinedione-2,4, leur procede de preparation et leurs applications en therapeutique |
CH654008A5 (fr) * | 1979-05-22 | 1986-01-31 | Nestle Sa | Procede de preparation de 1,3,7-trialkylxanthines. |
US4268511A (en) * | 1980-03-11 | 1981-05-19 | Berri-Balzac | 3-Amino(1H,3H)quinazoline-2,4-dione derivatives and their therapeutic applications |
BE882223A (fr) * | 1980-03-14 | 1980-09-15 | Berri Balzac | Derives d'amine-3 (1h, 3) quinazolinedione-2,4, leur procede de preparation et leurs applications en therapeutique |
JPS6425767A (en) * | 1987-04-03 | 1989-01-27 | Fujisawa Pharmaceutical Co | Production of quinazoline derivative or salt thereof |
ATE303994T1 (de) * | 1994-12-29 | 2005-09-15 | Univ California | Verbindungen für ceramid-vermittelter signalübertragung |
US6323201B1 (en) | 1994-12-29 | 2001-11-27 | The Regents Of The University Of California | Compounds for inhibition of ceramide-mediated signal transduction |
RU2199532C2 (ru) * | 1997-06-27 | 2003-02-27 | Фудзисава Фармасьютикал Ко., Лтд. | Сульфонамидное соединение |
JP2002540204A (ja) * | 1999-03-26 | 2002-11-26 | アストラゼネカ・アクチエボラーグ | 新規化合物 |
DE10106493B4 (de) | 2001-02-13 | 2010-11-04 | Plasmidfactory Gmbh & Co. Kg | Verfahren zur Herstellung von Nukleinsäuren |
PA8539401A1 (es) * | 2001-02-14 | 2002-10-28 | Warner Lambert Co | Quinazolinas como inhibidores de mmp-13 |
US6924295B2 (en) * | 2001-06-18 | 2005-08-02 | Ono Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
AU2002331362A1 (en) * | 2002-07-12 | 2004-02-02 | Warner-Lambert Company Llc | New alkynylated quinazolin compounds as mmp-13 inhibitors |
AU2002368151A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
TW543344B (en) * | 2002-10-25 | 2003-07-21 | Ritdisplay Corp | Organic light emitting diode and organic emitting material thereof |
DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
CN101795682A (zh) * | 2007-05-02 | 2010-08-04 | 波托拉医药品公司 | 直接起效和可逆的p2y12抑制剂的静脉内和口服给药 |
-
2008
- 2008-03-04 EA EA200901167A patent/EA200901167A1/ru unknown
- 2008-03-04 US US12/449,537 patent/US8633211B2/en not_active Expired - Fee Related
- 2008-03-04 MX MX2009009492A patent/MX2009009492A/es unknown
- 2008-03-04 AU AU2008223831A patent/AU2008223831B2/en not_active Ceased
- 2008-03-04 CA CA002678492A patent/CA2678492A1/en not_active Abandoned
- 2008-03-04 BR BRPI0808422-0A patent/BRPI0808422A2/pt not_active IP Right Cessation
- 2008-03-04 CN CN2008800070153A patent/CN101622234B/zh not_active Expired - Fee Related
- 2008-03-04 JP JP2009552192A patent/JP5390407B2/ja not_active Expired - Fee Related
- 2008-03-04 WO PCT/EP2008/052614 patent/WO2008107436A1/en active Application Filing
- 2008-03-04 KR KR1020097018534A patent/KR20090115953A/ko not_active Application Discontinuation
- 2008-03-04 EP EP08717374A patent/EP2132186A1/en not_active Withdrawn
-
2013
- 2013-12-16 US US14/107,119 patent/US20140187550A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008107436A1 (en) | 2008-09-12 |
KR20090115953A (ko) | 2009-11-10 |
US20140187550A1 (en) | 2014-07-03 |
US8633211B2 (en) | 2014-01-21 |
MX2009009492A (es) | 2009-09-15 |
AU2008223831A1 (en) | 2008-09-12 |
AU2008223831B2 (en) | 2012-07-05 |
JP2010520256A (ja) | 2010-06-10 |
CN101622234A (zh) | 2010-01-06 |
CA2678492A1 (en) | 2008-09-12 |
EP2132186A1 (en) | 2009-12-16 |
CN101622234B (zh) | 2013-08-07 |
JP5390407B2 (ja) | 2014-01-15 |
EA200901167A1 (ru) | 2010-04-30 |
US20100113774A1 (en) | 2010-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0808422A2 (pt) | Compostos orgânicos bicíclicos adequados para o tratamento de condições inflamatórias ou alérgicas | |
BRPI0916862A2 (pt) | compostos úteis para o tratamento de doenças degenerativas e inflamatórias | |
CR11019A (es) | 3-imidazolil-indoles para el tratamiento de enfermedades proliferativas | |
BRPI1015569A2 (pt) | compostos úteis para o tratamento de doenças degenerativas e inflamatórias. | |
BRPI0716844A2 (pt) | Inidores de quinase úteis para o tratamento de doenças proliferativas | |
BRPI1014759A2 (pt) | composto útil para o tratamento de doenças degenerativas e inflamatórias | |
BRPI0911923A2 (pt) | dispositivos filamentosos para o tratamento de defeitos vasculares | |
BRPI0918527A2 (pt) | compostos para o tratamento de disturbios do cns | |
DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
ES2525801T8 (es) | Composiciones y métodos para la prevención y el tratamiento de enfermedades autoinmunes | |
BR112012013260A2 (pt) | dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa | |
SMP200900082B (it) | Composti organici e loro utilizzazione | |
BRPI0815588A2 (pt) | Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano | |
BR112013014943A2 (pt) | compostos úteis para o tratamento de aids | |
ES2898695T8 (es) | Derivados de benzoxaborol para el tratamiento de infecciones bacterianas | |
BRPI0716435A2 (pt) | Compostos para o tratamento de doenças proliferativas | |
CO6801724A2 (es) | Composiciones y métodos para el tratamiento de la mielofibrosis | |
BRPI0915439A2 (pt) | composição tópica para o tratamento de ceratose actínica | |
BRPI0820677A2 (pt) | Misturas de compostos pesticidas | |
BRPI0911577A2 (pt) | derivados espiro-indol para o tratamento de doenças parasíticas. | |
BR112012004836A2 (pt) | pirazinilpiridinas úteis para o tratamento de doenças proliferativas | |
BRPI0813670A2 (pt) | Compostos para tratamento | |
BRPI0923567A2 (pt) | agentes antibactericidas novos para o tratamento de infecções gram positivas | |
DOP2010000373A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |